- UroToday Home
- Recent Abstracts
- Men's Health
BPH - Benign Prostatic Enlargement
Mechanistic targets for BPH and prostate cancer-a review.
September 26, 2020
An Indirect Comparison of Newer Minimally Invasive Treatments for Benign Prostatic Hyperplasia: A Network Meta-Analysis Model.
September 25, 2020
Prostatic anatomical parameters correlate with clinical characteristics suggestive of benign prostatic hyperplasia.
September 20, 2020
Patients with benign prostatic hyperplasia show shorter leukocyte telomere length but no association with telomerase gene polymorphisms in Han Chinese males.
September 20, 2020
Angiographic prostatic arterial anatomy in Turkish population with benign prostatic hyperplasia.
September 20, 2020
Cost analysis of alpha blocker treatments for benign prostatic hyperplasia in Medicare beneficiaries.
September 20, 2020
Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects.
September 13, 2020
The Effect of the Presence of Lower Urinary System Symptoms on the Prognosis of COVID-19: Preliminary Results of a Prospective Study.
September 11, 2020
Benign Prostatic Hyperplasia- what do we know?
September 10, 2020
[Sophisticated surgical management of distinctive patients with benign prostatic hyperplasia (BPH)].
September 6, 2020
Holmium laser enucleation of the prostate (HoLEP): size-independent gold standard for surgical management of benign prostatic hyperplasia.
September 5, 2020
Urinary and sexual function after treatment with temporary implantable nitinol device (iTind) in men with LUTS: 6-month interim results of the MT-06-study.
September 5, 2020
iTIND: the second-generation temporary implantable nitinol device for minimally invasive treatment of benign prostatic hyperplasia.
August 30, 2020